Aristotle University Of Thessaloniki (AUTH)
Δημογραφικά χαρακτηριστικά ιστορικό διάγνωσης συννοσηρότητες και βαρύτητα νόσου ασθενών με διαπυητική ιδρωταδενίτιδα σε σύγκριση με ομάδα ελέγχου
Abstract
dc:descriptionIntroduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory, relapsing, debilitating disease of the hair follicles, which usually presents itself after puberty with painful, deeply seated inflammatory lesions, located primarily in intertriginous areas. Its prevalence is estimated to be 0,40% (0,26%-0,63%), with reportedly more frequent manifestation in women comparing to men (2-3:1). Objective: To compare HS patients with either healthy controls or psoriasis patients regarding specific anthropometric characteristics, diagnostic delay, prevalence of specific comorbidities and specific disease severity parameters. Material and methods: A prospective cross-sectional study was performed in four parts. Patient recruitment took place in First Dermatology Department, Aristotle University of Thessaloniki, from March 2021 until September 2023. Data collection was performed during one visit. Adult patients with a HS diagnosis, based on current diagnostic criteria, and disease duration of at least 6 months were eligible for inclusion. Adult patients with a ratio of 1:1 were recruited as controls, matched for age and sex for the second part of the study and matched for age, sex and race for the third part. Primary outcomes were for the first part mean waist circumference (centimeters), for the second part mean time from disease commencement to diagnosis (years and months), for the third part prevalence of polycystic ovarian syndrome (PCOS) (percentage%) and for the fourth part mean work impairment (percentage%). Desired study sample was calculated to be 67 participants per group. SPSS (version 29, IBM Corp., Armonk, NY, USA) was used for statistical analysis. Results: 203 HS patients (mean age 39.7 years, [38.03, 41.38], 51,7% women) were recruited. 59,6% had Hurley stage II, mean International Hidradenitis Suppurativa Severity Score System was 4.86 [4.13, 5.59], mean maximum pain score over the past week was 4.39 [3.87, 4.9], and mean Dermatology Life Quality Index score was 9.03 [7.96, 10.11]. HS patients had greater body mass index (BMI) comparing to healthy controls (30.34 [29.28, 31.4] versus 27.47 [26.93, 28.00]) as well as greater waist circumference (104.32 [102.61, 106.63] versus 95.25 [93.64, 96.86]) with statistically significant difference ([1.44, 3.42] and [6.73, 11.41] respectively). Mean diagnostic delay was longer in HS patients (6.51 [5,42, 7,6] years or 78.5 [65,45, 91,54] months versus 6.58 [5.19, 7.96] months in psoriasis patients) with significance of difference [58.84, 85]. HS patients visited a physician a mean of 3.21 [2.6, 3.83] times before receiving the correct diagnosis, with the dermatologist making the wrong diagnosis in 57,4% of cases, followed by the general surgeon in 34.3% of those. The corresponding data in psoriasis patients were 1.14 [1.01, 2.1] medical visits (difference [0.5, 3.92]), with a wrong diagnosis having been made in few patients, more frequently by a general physician/internist (5.42%). Women with HS were 2.269 times more likely to have PCOS comparing to healthy controls (p=0.016). Mean total work impairment was 31.12% [26.14%, 36.10%] for HS patients and 4.95% [2.46%, 7.44%] for psoriasis patients (p<0.001). Mean absenteeism, presenteeism daily activity impairment was 10.14% [7.3%, 12.98%], 28.72% [24.1%, 33.34%], 27.29% [22.87%, 31.71%] respectively for HS patients and (2.22% [0.64%, 3.79%], 4.43% [2.23%, 6.63%] and 3.9% [1.77%, 6.02%] respectively for psoriasis patients (p<0,001 for all comparisons).Conclusions: Documenting of waist circumference by the dermatologist, along with other anthropometric data, such as height, weight and BMI, would be beneficial at reasonable intervals (6-monthly or annually). Adoption of measures to improve the education of physicians in general (medical school, specialty training, post-specialty training) in the field of HS, as well as to increase awareness among the general population (printed material, social media, implementation of diagnostic screening question in primary healthcare settings) could increase cases of timely diagnosis and improve prognosis. What is more, women with HS should be screened for symptoms/signs of PCOS by the dermatologist, referred to a gynaecologist, if necessary, and prescribed treatment suitable for both conditions. Last but not least, work impairment should be measured with appropriate tools, while documenting disease severity, and taken into consideration while making treatment decisions.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsentemeidou, Aikaterini
- Τσεντεμεΐδου, Αικατερίνη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56933